3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Renal Cell
4
Multiple Myeloma
3
Gastrointestinal Stromal Tumors
3
Neoplasms
2
Neoplasm Metastasis
2
Lymphoma
2
Gastrointestinal Neoplasms
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Metastatic Digestive System Neuroendocrine Tumor G1
1
Meningioma
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Lung Neoplasms
1
Hematologic Neoplasms
1
Glioma
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Hepatocellular
1
Carcinoma
1
Interventions
Irinotecan
2
tivozanib
1
repotrectinib
1
belinostat
1
atezolizumab
1
Topotecan
1
Specimen Handling
1
Magnetic Resonance Spectroscopy
1
Leucovorin
1
IFL protocol
1
Fluorouracil
1
Etoposide
1
Cisplatin
1
Biopsy
1
BAY 1895344
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Neuroendocrine
×
Sunitinib
×
30 days
×
Clear all
No trials found.